Cagrilintide is a long-acting synthetic amylin analogue studied for its role in appetite regulation, satiety and body-weight management. Amylin is a naturally occurring pancreatic hormone involved in signalling fullness. Cagrilintide is researched both independently and alongside semaglutide in the combination known as CagriSema.
Commonly researched areas of interest
Amylin-receptor signalling and appetite regulation.
Satiety pathways and food-intake responses.
Body-weight changes and energy balance.
Complementary actions of amylin and GLP-1 pathways.
Long-acting peptide pharmacology.
Common laboratory applications
Cagrilintide may be investigated in appropriately designed receptor-signalling assays, peptide-characterisation studies and experimental models examining amylin-mediated metabolic pathways. Suitability depends on the requirements of the individual research protocol.
For research use only
Cagrilintide is a long-acting synthetic amylin analogue studied for its role in appetite regulation, satiety and body-weight management. Amylin is a naturally occurring pancreatic hormone involved in signalling fullness. Cagrilintide is researched both independently and alongside semaglutide in the combination known as CagriSema.
Commonly researched areas of interest
Amylin-receptor signalling and appetite regulation.
Satiety pathways and food-intake responses.
Body-weight changes and energy balance.
Complementary actions of amylin and GLP-1 pathways.
Long-acting peptide pharmacology.
Common laboratory applications
Cagrilintide may be investigated in appropriately designed receptor-signalling assays, peptide-characterisation studies and experimental models examining amylin-mediated metabolic pathways. Suitability depends on the requirements of the individual research protocol.
For research use only